CLINICAL_TRIALS
trial_result
· 2014-04-21
Clinical Trial Update: NeoCart Phase 2 Clinical Trial [Phase 2]
Summary
Histogenics' NeoCart Phase 2 trial for articular cartilage damage has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Histogenics Corporation | Conditions: Articular Cartilage Damage | Phase 2 | Status: COMPLETED